Report Id: PGMM1118
Geriatric Medicine Market By Product (Analgesics, Antihypertensives, Statins, Antidiabetics, Proton Pump Inhibitor, Anticoagulant, Antipsychotic, Antidepressant); By Application (Cardiovascular, Arthritis, Neurological, Cancer, Osteoporosis, Respiratory) and by Regional Analysis - Global Forecast by 2023-2028
The Geriatric Medicine Market is expected to be around US$ 184254 Million by 2028 at a CAGR of 7% in the given forecast period.
COVID-19 Impact Analysis Report
"Get Latest Updated Reports as per the COVID-19 Impact"
Infopedia: Access Our All Reports Online at Affordable Price
CLICK HEREMARKET SNAPSHOT
Major Players
- GSK
- Boehringer Ingelheim
- Novartis
- Bristol-Myers Squibb
- Pfizer
Study period:
Fastest Growing Market:
2023-2028
APAC
Base Year:
Largest Market:
2022
North America
CAGR:
7
REPORT DESCRIPTION
Geriatric medicines, additionally called geriatrics is a division of medicines related with preventive, healing, clinical and social parts of illness for the most part among individuals that are matured more than 65 years or more. Without appropriate consideration, a maturing body perpetually loses invulnerability and geriatrics are exceedingly inclined to neurological, cardiovascular, and respiratory sicknesses, among others. Geriatric drugs are a forte part of therapeutic science that gives modified diagnostics and treatment choices for the elderly, and the market for the equivalent is thriving.
How Big is The Geriatric Medicine Market?
The Geriatric Medicine Market is expected to be around US$ 184254 Million by 2028 at a CAGR of 7% in the given forecast period.
The major driving factors of Geriatric Medicine Market are as follows:
- Rise in Chronis Diseases
- Apparent aging population
- Specialty clinics are mushrooming and governments are taking initiatives to promote geriatric care
The major restraining factors of Geriatric Medicine Market are as follows:
- Lack of proper knowledge and awareness in the rural parts of the world
- Side effects of geriatric medicines
- Absence of Patient Participation in Clinical Trials
The major opportunities of Geriatric Medicine Market are as follows:
- Holds Immense Potential for Geriatric Medicines in APAC
The Geriatric Medicine Market has been segmented as below:
By Product:
- Analgesics
- Antihypertensives
- Statins
- Antidiabetics
- Proton Pump Inhibitor
- Anticoagulant
- Antipsychotic
- Antidepressant
By Application:
- Cardiovascular
- Arthritis
- Neurological
- Cancer
- Osteoporosis
- Respiratory
The Geriatric Medicine Market is segmented on the lines of its product, application and regional. On the basis of product, it is segmented into Analgesics, Antihypertensives, Statins, Antidiabetics, Proton Pump Inhibitor, Anticoagulant, Antipsychotic, Antidepressant. Based on application classification it covers Cardiovascular, Arthritis, Neurological, Cancer, Osteoporosis and Respiratory. The Geriatric Medicine Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, and Rest of World. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Geriatric Medicine Market and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Geriatric Medicine Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
Report Scope:
The scope of the report includes a detailed study of Geriatric Medicine Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include GSK, Boehringer Ingelheim, Novartis, Bristol-Myers Squibb, Pfizer, Eli Lilly, Abbott, AstraZeneca, Merck, Sanofi S.A. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
Reasons to Buy this Report:
- Obtain the most up to date information available on all Geriatric Medicine Market.
- Identify growth segments and opportunities in the industry.
- Facilitate decision making on the basis of strong historic and forecast of Geriatric Medicine Market.
- Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our New Reports :-
1. Introduction
1.1 Report Description
1.2 Markets Covered
1.3 Stakeholders
2. Research Methodology
2.1 Research Data
2.2 Market Size Estimation and Data Triangulation
2.3 Research Assumptions
3. Report Summary
4. Market Overview
4.1 Introduction
4.2 Drivers
4.3 Restrains
4.4 Industry Trends
4.5 Porter’s Five Forces Analysis
5. Geriatric Medicine Market Analysis, By Product
5.1 Analgesics
5.2 Antihypertensives
5.3 Statins
5.4 Antidiabetics
5.5 Proton Pump Inhibitor
5.6 Anticoagulant
5.7 Antipsychotic
5.8 Antidepressant
6. Geriatric Medicine Market Analysis, By Application
6.1 Cardiovascular
6.2 Arthritis
6.3 Neurological
6.4 Cancer
6.5 Osteoporosis
6.6 Respiratory
7. Geriatric Medicine Market Analysis, By Region
7.1 North America
7.2 Europe
7.3 Asia-Pacific
7.4 Rest of the World
8. Competitive Overview
8.1 Introduction
8.2 New Product Launches
8.3 Acquisitions
8.4 Agreements, Partnerships, And Collaborations
8.5 Expansions
9. Company Profiles
9.1 GSK
9.2 Boehringer Ingelheim
9.3 AstraZeneca
9.4 Merck
9.5 Bristol-Myers Squibb
9.6 Novartis
9.7 Eli Lilly
9.8 Abbott
9.9 Pfizer
9.10 Sanofi S.A.
The Geriatric Medicine Market has been segmented as below:
By Product:
- Analgesics
- Antihypertensives
- Statins
- Antidiabetics
- Proton Pump Inhibitor
- Anticoagulant
- Antipsychotic
- Antidepressant
By Application:
- Cardiovascular
- Arthritis
- Neurological
- Cancer
- Osteoporosis
- Respiratory
By Regional Analysis:
- North America
- Europe
- Asia-Pacific
- Rest of the World
Got a question? We've got answers. If you have some other questions, see our support center.
What is the predicted growth rate of Geriatric Medicine Market?
The market is expected to grow at a CAGR of 7% during the study period (2023-2028)
How big is the Geriatric Medicine Market value?
The Geriatric Medicine Market is expected to be around US$ 184254 Million by 2028.
What is the segment’s covered for the Geriatric Medicine Market?
The segment included in the Geriatric Medicine Market is Product, Application and region.
Who are the major key vendors in the Geriatric Medicine Market?
Some key players operating in the Geriatric Medicine Market include GSK, Boehringer Ingelheim, Novartis, Bristol-Myers Squibb, Pfizer, Eli Lilly, Abbott, AstraZeneca, Merck
What are the different forms of the report available?
We can offer several formats of the market research reports including,
• PDF
• PPT
• Spreadsheet/ Workbook
© 2020 COPYRIGHT : MARKET RESEARCH ENGINE